High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 7, 2007, Pages 2508-2513

  Chow, Viola C Y ^a   Hawkey, Peter M ^b   Chan, Edward W C ^a   Chin, Miu L ^a   Au, T K ^a   Fung, Danny K C ^a   Chan, Raphael C Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFOTAXIME; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; MINOCYCLINE; NETILMICIN; PENICILLIN G; STREPTOMYCIN; SUPEROXIDE DISMUTASE; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; ERMB GENE; HONG KONG; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SODA GENE; STREPTOCOCCUS; STREPTOCOCCUS PASTEURIANUS; TRANSPOSON; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENTAMICINS; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; STREPTOCOCCUS;

EID: 34447254948     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00603-06     Document Type: Article

References (44)

1. Bonafede, M. E., L. L. Carias, and L. B. Rice. 1997. Enterococcal transposon Tn5384: evolution of a composite transposon through cointegration of enterococcal and staphylococcal plasmids. Antimicrob. Agents Chemother. 41:1854-1858.
2. Burns, C. A., M. McCaughey, and C. B. Lauter. 1985. The association of S. bovis fecal carriage and colon neoplasia: a possible relationship with polyps and their premalignant potential. Am. J. Gastroenterol. 80:42-46.
3. Buu-Hoi, A., C. Le Bouguenec, and T. Horaud. 1990. High-level chromosomal gentamicin resistance in Streptococcus agalactiae (group B). Antimicrob. Agents Chemother. 34:985-988.
4. Chow, J. W., V. Kak, I. You, S. J. Kao, J. Petrin, D. B. Clewell, S. A. Lerner, G. H. Miller, and K. J. Shaw. 2001. Aminoglycoside resistance genes aph(2″)Ib and aac(6′)Im detected together in strains of both Escherichia coli and Enterococcus faecium. Antimicrob. Agents Chemother. 45:2691-2694.
5. Coykendall, A. L. 1989. Classification and identification of the viridans streptococci. Clin. Microbiol. Rev. 2:315-328.
6. David, F., G. Cespedes, F. Delbos, and T. Horaud. 1993. Diversity of chromosomal genetic elements and gene identification in antibiotic-resistant strains of Streptococcus pneumoniae and Streptococcus bovis. Plasmid 29:147-153.
7. Duck, W. M., C. D. Steward, S. N. Banerjee, J. E. McGowa, Jr., and F. C. Tenover. 2003. Optimization of computer software setting improves accuracy of pulsed-field gel electrophoresis macrorestriction fragment pattern analysis. J. Clin. Microbiol. 41:3035-3042.
8. Enzler, M. J., M. S. Rouse, N. K. Henry, J. E. Geraci, and W. R. Wilson. 1987. In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis. J. Infect. Dis. 155:954-958.
9. Facklam, R. 2002. What happened to the streptococci?: overview of taxonomic and nomenclature changes. Clin. Microbiol. Rev. 15:613-630.
10. Farber, B. F., G. M. Eliopoulos, J. I. Ward, K. Ruoff, and R. C. Moellering, Jr. 1983. Resistance to penicillin-streptomycin synergy among clinical isolates of viridans streptococci. Antimicrob. Agents Chemother. 24:871-875.
11. Farber, B. F., and Y. Yee. 1987. High-level aminoglycoside resistance mediated by aminoglycoside-modifying enzymes among viridans streptococci: implications for the therapy for endocarditis. J. Infect. Dis. 155:948-953.
12. Gonzalez-Quintela, A., C. Martinez-Rey, J. F. Castroagudin, M. C. Rajo-Iglesias, and M. J. Dominguez-Santalla. 2001. Prevalence of liver disease in patients with Streptococcus bovis bacteraemia. J. Infect. 42:116-119.
13. Grattard, F., J. Etienne, B. Pozzetto, F. Tardy, O. G. Gaudin, and J. Fleurette. 1993. Characterization of unrelated strains of Staphylococcus schleiferi by using ribosomal DNA fingerprinting, DNA restriction patterns, and plasmid profiles. J. Clin. Microbiol. 31:812-818.
14. Hodel-Christian, S. L., and B. E. Murray. 1991. Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus faecalis and comparison to staphylococcal transposons Tn4001 and Tn4031. Antimicrob. Agents Chemother. 35:1147-1152.
15. Hoen, B., F. Alla, C. Selton-Suty, I. Beguinot, A. Bouvet, S. Briancon, J. P. Casalta, N. Danchin, F. Delahaye, J. Etienne, V. Le Moing, C. Leport, J. L. Mainardi, R. Ruimy, F. Vandenesch, and the Association pour l'Etude et la Prevention de l'Endocarditeinfectieuse (AEPEI) Study Group. 2002. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288:75-81.
16. Horaud, T., G. de Cespedes, and P. Trieu-Cuot. 1996. Chromosomal gentamicin resistance transposon Tn3706 in Streptococcus agalactiae B128. Antimicrob. Agents Chemother. 40:1085-1090.
17. Horodniceanu, T., L. Bougueleret, N. El-Solh, G. Bieth, and F. Delbos. 1979. High level plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob. Agents Chemother. 16:686-689.
18. Horodniceanu, T., A. Buu-Hoi, F. Delbos, and G. Bietb. 1982. High-level aminoglycoside resistance in group A, B, G, D (Streptococcus bovis), and viridans streptococci. Antimicrob. Agents Chemother. 21:176-179.
19. Kao, S. J., I. You, D. B. Clewell, S. M. Dorabedian, M. J. Zervos, J. Petrin, K. J. Shaw, and J. W. Chow. 2000. Detection of the high-level aminoglycoside resistance gene aph(2″)-Ib in Enterococcus faecium. Antimicrob. Agents Chemother. 44:2876-2879.
20. Kaufhold, A., and E. Potgieter. 1993. Chromosomally mediated high-level gentamicin resistance in Streptococcus mitis. Antimicrob. Agents Chemother. 37:2740-2742.
21. Klein, R. S., M. T. Catalano, S. C. Edberg, J. L. Casey, and N. H. Steigbigel. 1979. Streptococcus bovis septicemia and carcinoma of the colon. Ann. Intern. Med. 91:560-562.
22. Klein, R. S., R. A. Recco, M. T. Catalano, S. C. Edberg, J. I. Casey, and N. H. Steigbigel. 1977. Association of Streptococcus bovis with carcinoma of the colon. N. Engl. J. Med. 297:800-802.
23. Kupferwasser, I., H. Darius, A. M. Muller, S. Mohr-Kahaly, I. Westermeier, H. Oelert, R. Erbel, and J. Meyer. 1998. Clinical and morphological characteristics in Streptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases. Heart 80:276-280.
24. Leclercq, R., C. Huet, M. Picherol, P. Trieu-Cuot, and C. Poyart. 2005. Genetic basis of antibiotic resistance in clinical isolates of Streptococcus gallolyticus. Antimicrob. Agents Chemother. 49:1646-1648.
25. Lyon, B. R., J. W. May, and R. A. Skuray. 1984. Tn4001: a gentamicin and kanamycin resistance transposon in Staphylococcus aureus. Mol. Gen. Genet. 193:554-556.
26. Moellering, R. C., Jr., B. K. Watson, and L. J. Kunz. 1974. Endocarditis due to group D streptococci: comparison of disease caused by Streptococcus bovis with that produced by the enterococci. Am. J. Med. 57:239-250.
27. Murray, H. W., and R. B. Roberts. 1978. Streptococcus bovis bacteremia and underlying gastrointestinal disease. Arch. Intern. Med. 138:1097-1099.
28. National Committee for Clinical Laboratory Standards. 2006. Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement. M100-S16 (M7). National Committee for Laboratory Standards, Wayne, PA.
29. Patterson, J. E., and M. J. Zervos. 1990. High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. Rev. Infect. Dis. 12:644-652.
30. Renneberg, J., L. L. Niemann, and E. Gutschik. 1997. Antimicrobial susceptibility of 278 streptococcal blood isolates to seven antimicrobial agents. J. Antimicrob. Chemother. 39:135-140.
31. Reynolds, J. G., E. Silva, and W. M. McCornack. 1983. Association of Streptococcus bovis bacteremia with bowel disease. J. Clin. Microbiol. 17:696-697.
32. Rice, L. B., G. M. Eliopoulos, C. Wennasten, D. Goldmann, G. A. Jacoby, and R. C. Moellering, Jr. 1991. Chromosomally mediated β-lactamase production and gentamicin resistance in Enterococcus faecalis. Antimicrob. Agents Chemother. 35:272-276.
33. Rice, L. B., L. L. Carias, and S. H. Marshall. 1995. Tn5384, a composite enterococcal mobile element conferring resistance to erythromycin and gentamicin whose ends are directly repeated copies of IS256. Antimicrob. Agents Chemother. 39:1147-1153.
34. Ruoff, K. L., R. A. Whiley, and D. Beighton. 1999. Streptococcus, p. 283-296. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, DC.
35. Sambrook, J., E. F. Fritscb, and R. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
36. Teng, L. J., P. R. Hsueh, S. W. Ho, and K. T. Luh. 2001. High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. Antimicrob. Agents Chemother. 45:3362-3365.
37. Thal, L. A., J. W. Chow, J. E. Patterson, M. B. Perri, S. Donabedian, D. B. Clewell, and M. J. Zervos. 1993. Molecular characterization of highly gentamicin resistant Enterococcus faecalis isolates lacking high-level streptomycin resistance. Antimicrob. Agents Chemother. 37:134-137.
38. Tripodi, M. F., L. E. Adinolfi, E. Ragone, E. Durante Mangoni, R. Fortunato, D. Iarussi, G. Ruggiero, and R. Utili. 2004. Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor. Clin. Infect. Dis. 38:1394-1400.
39. Tsai, S. F., M. J. Zervos, D. B. Clewell, S. M. Donabedian, D. F. Sahm, and J. W. Chow. 1998. A new high-level gentamicin resistance gene, aph(2″)-Id, in Enterococcus spp. Antimicrob. Agents Chemother. 42:1229-1232.
40. Watanakunakorn, C., and C. Glotzbecker. 1977. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group D streptococci and viridans streptococci. J. Med. Microbiol. 10:133-138.
41. Wilson, W. R., A. W. Karchmer, A. S. Dajani, K. A. Taubert, A. Bayer, and D. Kaye. 1995. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganisms. JAMA 274:1706-1713.
42. Woodford, N., E. McNamara, E. Smyth, and R. C. George. 1992. High-level resistance to gentamicin in Enterococcus faecium. J. Antimicrob. Chemother. 29:395-403.
43. Working Party of the British Society for Antimicrobial Chemotherapy. 1998. Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Heart 79:207-210.
44. Zarkin, B. A., K. D. Lillemoe, J. L. Cameron, P. N. Effron, T. H. Magnusson, and H. A. Pitt. 1990. The triad of Streptococcus bovis bacteremia, colonic pathology and liver disease. Ann. Surg. 211:786-792.